Stemtech Appoints John W. Meyer To President And COO

Stemtech Corporation (“Stemtech”) (OTC:GNTW), a leading nutraceutical company and a pioneer in the field of stem cell nutrition, announced today that it has appointed John W. Meyer as President and COO, in addition to serving as a member of the Board of Directors.

Mr. Meyer joined Stemtech in 2006 and oversees all global operations.

His responsibilities now include the role of President, where he will lead all aspects of Stemtech, reporting to CEO Charles S. Arnold and the Board of Directors. All functional departments and international operations are his responsibility to drive growth and expansion of the company.

Prior to joining Stemtech, John worked for other well-known network marketing companies, such as Shaklee and Arbonne International for over ten years. He also worked for over a decade in third party logistics on projects for Fortune 100 companies.

He brought this experience and more to Stemtech, overseeing operations for the last fifteen years.

“In addition to his position of COO, we are proud to promote John to the role of President in recognition of his contribution and plans for leading Stemtech’s international growth going forward,”

said CEO Charles S. Arnold.

“John has been a mainstay of Stemtech since the inception of the company, and he is passionate about sharing both the benefits of our all natural, plant-based products, and the income earning business opportunity which Stemtech represents.

 

He clearly has a comprehensive understanding of the business, and values our field of Independent Business Partners, customers and employees.

 

It is a pleasure to work with John, and we believe that his deep commitment to sustainable growth for the company will be beneficial for all Stemtech stakeholders.”

About Stemtech Corporation

Stemtech Corporation, a leading nutraceutical company with a direct sales distribution model, was founded on April 18, 2018, after acquiring the operations from its predecessor Stemtech International, Inc. which was founded in 2005. From 2010 through 2015, Stemtech International, Inc., was recognized four separate times on the Inc. 5000 Fastest-Growing Companies list. In 2018, the Company underwent an extensive executive reorganization, and continued operations under new leadership.

Stemtech specializes in creating products and formulas that are patent-protected in the U.S. and in select international markets. The Company’s patented formulas help the release, circulation and migration of the body’s adult stem cells from its bone marrow.

The Company markets its products under the following brands: RCM System, stemrelease3™, Stemflo® MigraStem™, DermaStem®, DermaStem Lift, OraStem® (Oral Health Care), and D-Fuze™. Its products are all-natural and plant-based and manufactured under cGMP (Current Good Manufacturing Practices) under the auspices of the Dietary Supplemental Health and Education Act (DSHEA). For more information, please visit www.stemtech.com.